Predictive oncology strengthens offerings with gmp lab and addition of leading expert in formulation development

Eagan, minn., sept. 19, 2022 (globe newswire) -- predictive oncology (nasdaq: poai) today announced several key developments to further strengthen the company's offerings for pharmaceutical and biotech customers.

POAI Ratings Summary

POAI Quant Ranking